Animal models of headache: from bedside to bench and back to bedside (Q37699421)

22 August 2017

1 reference

title

Animal models of headache: from bedside to bench and back to bedside (English)

1 reference

22 August 2017

1 reference

5

Peter J Goadsby

1 reference

22 August 2017

Anna P Andreou

1

1 reference

22 August 2017

Oliver Summ

series ordinal

2

1 reference

22 August 2017

Annabelle R Charbit

series ordinal

3

1 reference

22 August 2017

Marcela Romero-Reyes

series ordinal

4

1 reference

22 August 2017

1 March 2010

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

22 August 2017

1 reference

22 August 2017

10

1 reference

22 August 2017

3

1 reference

22 August 2017

389-411

1 reference

Epidemiology of headache in a general population--a prevalence study.

22 August 2017

1 reference

The global burden of disease study: implications for neurology

21 January 2018

1 reference

The International Classification of Headache Disorders: 2nd edition

21 January 2018

1 reference

Migraine with aura and migraine without aura: an epidemiological study

21 January 2018

1 reference

Origin and distribution of cerebral vascular innervation from superior cervical, trigeminal and spinal ganglia investigated with retrograde and anterograde WGA-HRP tracing in the rat.

21 January 2018

1 reference

Axonal tracing of autonomic nerve fibers to the superficial temporal artery in the rat.

21 January 2018

1 reference

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

21 January 2018

1 reference

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

21 January 2018

1 reference

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

21 January 2018

1 reference

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

21 January 2018

1 reference

Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow

21 January 2018

1 reference

The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat.

21 January 2018

1 reference

Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat.

21 January 2018

1 reference

The trigeminocervical complex and migraine: current concepts and synthesis

21 January 2018

1 reference

Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat.

21 January 2018

1 reference

21 January 2018

Neuroimaging of migraine

1 reference

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

21 January 2018

1 reference

Central sensitization theory of migraine: clinical implications

21 January 2018

1 reference

Brain stem activation in spontaneous human migraine attacks

21 January 2018

1 reference

Brainstem activation specific to migraine headache.

21 January 2018

1 reference

Advances in the understanding of headache

21 January 2018

1 reference

Headache secondary to deep brain implantation

21 January 2018

1 reference

Headache may arise from perturbation of brain.

21 January 2018

1 reference

Regional cerebral blood flow and oxygen metabolism during migraine with and without aura.

21 January 2018

1 reference

Timing and topography of cerebral blood flow, aura, and headache during migraine attacks

21 January 2018

1 reference

Genetic loading in familial migraine with aura

21 January 2018

1 reference

Migraine--current understanding and treatment

21 January 2018

1 reference

Glyceryl trinitrate triggers premonitory symptoms in migraineurs

21 January 2018

1 reference

CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion.

21 January 2018

1 reference

Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs

21 January 2018

1 reference

21 January 2018

Nitric oxide in migraine

1 reference

Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy

21 January 2018

1 reference

Migraine headache is not associated with cerebral or meningeal vasodilatation--a 3T magnetic resonance angiography study

21 January 2018

1 reference

PACAP38 induces migraine-like attacks in patients with migraine without aura

21 January 2018

1 reference

Tissue blood flow and localization of arteriovenous anastomoses in pigs with microspheres of four different sizes.

21 January 2018

1 reference

Assessment of anti-migraine potential of a novel alpha-adrenoceptor agonist S19014: effects on porcine carotid and regional haemodynamics and human coronary artery

21 January 2018

1 reference

Sumatriptan does not affect arteriovenous oxygen differences in jugular and cubital veins in normal human subjects

21 January 2018

1 reference

5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression

21 January 2018

1 reference

Calcitonin gene-related peptide but not substance P mimics capsaicin-induced coronary vasodilation in the pig.

21 January 2018

1 reference

Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo.

21 January 2018

1 reference

Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry

21 January 2018

1 reference

Expression of calcitonin receptor-like receptor and receptor-activity-modifying proteins in human cranial arteries

21 January 2018

1 reference

Contractile responses to sumatriptan and ergotamine in the rabbit saphenous vein: effect of selective 5-HT(1F) receptor agonists and PGF(2alpha).

21 January 2018

1 reference

Selective seratonin 1F (5-HT(1F)) receptor agonist LY334370 for acute migraine: a randomised controlled trial

21 January 2018

1 reference

LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine.

21 January 2018

1 reference

Neuropeptides in migraine and cluster headache

21 January 2018

1 reference

Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat--intravital microscope studies

21 January 2018

1 reference

The effect of adrenergic compounds on neurogenic dural vasodilatation

21 January 2018

1 reference

Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat.

21 January 2018

1 reference

Lanepitant, an NK-1 antagonist, in migraine prevention

21 January 2018

1 reference

Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study

21 January 2018

1 reference

Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat

21 January 2018

1 reference

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.

21 January 2018

1 reference

Topiramate inhibits trigeminovascular activation: an intravital microscopy study

21 January 2018

1 reference

Neurogenic inflammation in the context of migraine

21 January 2018

1 reference

Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism

21 January 2018

1 reference

Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons.

21 January 2018

1 reference

Study of an adenosine A1 receptor agonist on trigeminally evoked dural blood vessel dilation in the anaesthetized rat

21 January 2018

1 reference

Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.

21 January 2018

1 reference

CGRP may play a causative role in migraine

21 January 2018

1 reference

The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels

21 January 2018

1 reference

Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels

21 January 2018

1 reference

Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception

21 January 2018

1 reference

Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine

21 January 2018

1 reference

The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs

21 January 2018

1 reference

Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons.

21 January 2018

1 reference

Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells

21 January 2018

1 reference

Possible antimigraine mechanisms of action of the 5HT1F receptor agonist LY334370.

21 January 2018

1 reference

Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation

21 January 2018

1 reference

Effects of the 5-HT1 receptor agonists, sumatriptan and CP 93,129, on dural arterial flow in the rat.

21 January 2018

1 reference

Lack of a role for substance P in the control of dural arterial flow

21 January 2018

1 reference

Involvement of nitric oxide in the modulation of dural arterial blood flow in the rat.

21 January 2018

1 reference

Nitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flow

21 January 2018

1 reference

Involvement of capsaicin-sensitive afferent nerves in the proteinase-activated receptor 2-mediated vasodilatation in the rat dura mater

21 January 2018

1 reference

Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater.

21 January 2018

1 reference

Somatostatin reduces the meningeal arterial blood flow in the rat.

21 January 2018

1 reference

Sensitization of meningeal sensory neurons and the origin of headaches

21 January 2018

1 reference

Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice

21 January 2018

1 reference

Neurogenically Mediated Plasma Extravasation in Dura Mater: Effect of Ergot Alkaloids: A Possible Mechanism of Action in Vascular Headache

21 January 2018

1 reference

Effects of parecoxib on plasma protein extravasation and c-fos expression in the rat.

21 January 2018

1 reference

Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine

21 January 2018

1 reference

The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater

21 January 2018

1 reference

Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis.

21 January 2018

1 reference

Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation

21 January 2018

1 reference

Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine.

21 January 2018

1 reference

The non-peptide NK-1 receptor antagonist LY303870 inhibits neurogenic dural inflammation in guinea pigs

21 January 2018

1 reference

Neurogenic inflammation and migraine: implications for the therapeutics

21 January 2018

1 reference

Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.

21 January 2018

1 reference

Delayed inflammation in rat meninges: implications for migraine pathophysiology.

21 January 2018

1 reference

GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain

21 January 2018

1 reference

Migraine can be induced by sildenafil without changes in middle cerebral artery diameter

21 January 2018

1 reference

Recent advances in understanding migraine mechanisms, molecules and therapeutics

21 January 2018

1 reference

Stimulus-transcription coupling in neurons: role of cellular immediate-early genes

21 January 2018

1 reference

The effects of pyrilamine and cimetidine on mRNA C-fos expression and nociceptive flinching behavior in rats.

21 January 2018

1 reference

Differential patterns of c-fos mRNA expression in the amygdaloid nuclei induced by chemical somatic and visceral noxious stimuli in rats

21 January 2018

1 reference

The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study.

21 January 2018

1 reference

Vascular head pain selectively activates ventrolateral periaqueductal gray in the cat.

21 January 2018

1 reference

Serotonin depletion increases nociception-evoked trigeminal NMDA receptor phosphorylation

21 January 2018

1 reference

Role of central dopaminergic circuitry in pain processing and nitroglycerin-induced hyperalgesia

21 January 2018

1 reference

A neurohistochemical blueprint for pain-induced loss of appetite.

21 January 2018

1 reference

Different neuronal populations of the rat median preoptic nucleus express c-fos during sleep and in response to hypertonic saline or angiotensin-II.

21 January 2018

1 reference

Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME.

21 January 2018

1 reference

Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.

21 January 2018

1 reference

Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine.

21 January 2018

1 reference

Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis

21 January 2018

1 reference

The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis

21 January 2018

1 reference

Glutamate activates c-fos in glial cells via a novel mechanism involving the glutamate receptor subtype mGlu5 and the transcriptional repressor DREAM.

21 January 2018

1 reference

The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid

21 January 2018

1 reference

5-Hydroxytryptamine(1B/1D) and 5-hydroxytryptamine1F receptors inhibit capsaicin-induced c-fos immunoreactivity within mouse trigeminal nucleus caudalis

21 January 2018

1 reference

Melatonin treatment decreases c-fos expression in a headache model induced by capsaicin.

21 January 2018

1 reference

Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus

21 January 2018

1 reference

Fos-like immunoreactivity in forebrain regions following self-stimulation of the lateral hypothalamus and the ventral tegmental area.

21 January 2018

1 reference

Induction of Fos in glia-like cells after focal brain injury but not during wallerian degeneration.

21 January 2018

1 reference

Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat.

21 January 2018

1 reference

Trigeminal ganglion stimulation increases facial skin blood flow in the rat: a major role for calcitonin gene-related peptide

21 January 2018

1 reference

Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation

21 January 2018

1 reference

Response of brainstem trigeminal neurons to electrical stimulation of the dura.

21 January 2018

1 reference

Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation.

21 January 2018

1 reference

Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling

21 January 2018

1 reference

Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study.

21 January 2018

1 reference

Dopamine inhibits trigeminovascular transmission in the rat.

21 January 2018

1 reference

Rizatriptan has central antinociceptive effects against durally evoked responses.

21 January 2018

1 reference

Differential effects of the 5HT1B/1D receptor agonist naratriptan on trigeminal versus spinal nociceptive responses.

21 January 2018

1 reference

Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist

21 January 2018

1 reference

The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus.

21 January 2018

1 reference

Topiramate inhibits trigeminovascular neurons in the cat.

21 January 2018

1 reference

Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors.

21 January 2018

1 reference

Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission.

21 January 2018

1 reference

Memantine in the preventive treatment of refractory migraine

21 January 2018

1 reference

Paracetamol: new vistas of an old drug

21 January 2018

1 reference

Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat.

21 January 2018

1 reference

Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex

21 January 2018

1 reference

The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission

21 January 2018

1 reference

The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids

21 January 2018

1 reference

Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat.

21 January 2018

1 reference

The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.

21 January 2018

1 reference

Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryl trinitrate.

21 January 2018

1 reference

Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.

21 January 2018

1 reference

Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat.

21 January 2018

1 reference

Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex

21 January 2018

1 reference

GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil

21 January 2018

1 reference

Anticonvulsants in migraine prophylaxis: a Cochrane review.

21 January 2018

1 reference

Topiramate: a review of preclinical, pharmacokinetic, and clinical data

21 January 2018

1 reference

Large conductance calcium-activated potassium channels (BKCa) modulate trigeminovascular nociceptive transmission

21 January 2018

1 reference

Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input.

21 January 2018

1 reference

Cutaneous allodynia in the migraine population

21 January 2018

1 reference

Deconstructing migraine headache into peripheral and central sensitization

21 January 2018

1 reference

Migraine, allodynia, sensitisation and all of that ...

21 January 2018

1 reference

Observations on 500 cases of migraine and allied vascular headache

21 January 2018

1 reference

Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat.

21 January 2018

1 reference

Neurochemistry of trigeminal activation in an animal model of migraine.

21 January 2018

1 reference

Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine

21 January 2018

1 reference

Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization.

21 January 2018

1 reference

Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors

21 January 2018

1 reference

Sensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusion

21 January 2018

1 reference

Sensitization of meningeal nociceptors: inhibition by naproxen

21 January 2018

1 reference

Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan

21 January 2018

1 reference

Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception

21 January 2018

1 reference

Differential effects on the internal and external carotid circulation of the monkey evoked by locus coeruleus stimulation.

21 January 2018

1 reference

Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine.

21 January 2018

1 reference

The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods.

21 January 2018

1 reference

Origin and termination of the diencephalo-spinal dopamine system in the rat.

21 January 2018

1 reference

Neurons of the dopaminergic/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: an electrophysiological and immunohistochemical study

21 January 2018

1 reference

Stimulation of cranial vessels excites nociceptive neurones in several thalamic nuclei of the cat.

21 January 2018

1 reference

Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?

21 January 2018

1 reference

Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target?

21 January 2018

1 reference

GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus

21 January 2018

1 reference

Extracellular glutamate, aspartate and arginine increase in the ventral posterolateral thalamic nucleus during nociceptive stimulation

21 January 2018

1 reference

Evidence of a genetic factor in migraine with aura: a population-based Danish twin study

21 January 2018

1 reference

Migraine: gene mutations and functional consequences

21 January 2018

1 reference

Impaired neurotransmitter release and elevated threshold for cortical spreading depression in mice with mutations in the alpha1A subunit of P/Q type calcium channels

21 January 2018

1 reference

Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice

21 January 2018

1 reference

Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine

21 January 2018

1 reference

The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online.

21 January 2018

1 reference

Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations.

21 January 2018

1 reference

Na,K-ATPase and the role of alpha isoforms in behavior

21 January 2018

1 reference

Episodic dural stimulation in awake rats: a model for recurrent headache

21 January 2018

1 reference

Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines

21 January 2018

1 reference

Role of calcitonin gene-related peptide in light-aversive behavior: implications for migraine

21 January 2018

1 reference

Spreading depression in human neocortical slices

21 January 2018

1 reference

Patterns of neurotransmitter receptor distributions following cortical spreading depression.

21 January 2018

1 reference

Activation of c-fos in the brain

21 January 2018

1 reference

Distinct vascular conduction with cortical spreading depression

21 January 2018

1 reference

Cortical spreading depression-new insights and persistent questions.

21 January 2018

1 reference

Mechanically-induced cortical spreading depression associated regional cerebral blood flow changes are blocked by Na+ ion channel blockade

21 January 2018

1 reference

Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine.

21 January 2018

1 reference

An experimental model of migraine with aura: cortical hypoperfusion following spreading depression in the awake and freely moving rat.

21 January 2018

1 reference

Unilateral cortical spreading depression induced by sound in rats.

21 January 2018

1 reference

Spreading depression: from serendipity to targeted therapy in migraine prophylaxis

21 January 2018

1 reference

Suppression of cortical spreading depression in migraine prophylaxis

21 January 2018

1 reference

Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan

21 January 2018

1 reference

Reduced threshold for cortical spreading depression in female mice.

21 January 2018

1 reference

The effect of estrogen and progesterone on spreading depression in rat neocortical tissues.

21 January 2018

1 reference

Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis

21 January 2018

1 reference

High-flow oxygen for treatment of cluster headache: a randomized trial

21 January 2018

1 reference

Paroxysmal hemicrania: a prospective clinical study of 31 cases

21 January 2018

1 reference

CNS projections to the pterygopalatine parasympathetic preganglionic neurons in the rat: a retrograde transneuronal viral cell body labeling study

21 January 2018

1 reference

High-frequency stimulation of the facial nerve results in local cortical release of vasoactive intestinal polypeptide in the anesthetised cat.

21 January 2018

1 reference

Noxious chemical stimulation of rat facial mucosa increases intracranial blood flow through a trigemino-parasympathetic reflex--an experimental model for vascular dysfunctions in cluster headache

21 January 2018

1 reference

Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies

21 January 2018

1 reference

Autonomic activation in experimental trigeminal pain

21 January 2018

1 reference

Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents

21 January 2018

1 reference

Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics

21 January 2018

1 reference

Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine

21 January 2018

1 reference

Familial Hemiplegic Migraine Type 1 Shows no Hypersensitivity to Nitric Oxide

21 January 2018

1 reference

Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype

21 January 2018

1 reference

Regional Variations in the Prevalence of Migraine and Tension-Type Headache Applying the new IHS Criteria: The German DMKG Headache Study

21 January 2018

1 reference

Induction of c-fos-like protein in spinal cord neurons following sensory stimulation

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.10.16

1 reference

22 August 2017

1 reference